IKP Core Facility

Biostatistics/Bioinformatics, Pharmacometrics and Digital Science

Team

Dr. Stefan Winter
Biostatician / Bioinformatician
Tel+49-711-8101-5704
stefan.winter@ikp-stuttgart.de
Go to profile
Dr. Florian Büttner
Bioinformatician
Go to profile
Dr. Regina Bohnert
Bioinformatician
Go to profile
Dr. Simeon Rüdesheim
Expert for Pharmacometrics
Go to profile
M. Sc. Hannah Heinrich
Bioinformatician
Tel+49-711-8101 2832
hannah.heinrich@ikp-stuttgart.de
Bernd Borstel
Network and IT Administration
Tel+49-711-8101 5971
bernd.borstel@ikp-stuttgart.de

Biostatistics and Bioinformatics

The Biostatistics and Bioinformatics Core Facility provides expert guidance and support for processing, preparing, and analyzing a wide range of biological, clinical, and pathological data. The facility utilizes established, standardized workflows for processing next-generation sequencing data, including pipeline solutions from the nf-core community project, ensuring efficient and reproducible handling of biomaterial data. Services include experiment planning (e.g., sample size estimation), selection of appropriate technical methodologies, and advanced biostatistical and bioinformatics analyses. The team is skilled in managing high-dimensional and heterogeneous datasets using scripting languages (e.g., R, Python) and scalable computing resources. Analytical approaches encompass supervised methods (e.g., regression, classification, survival analysis) and unsupervised techniques (e.g., clustering, dimensionality reduction), along with deep learning methods (e.g., convolutional neural networks) for image analysis, including tasks such as feature extraction, segmentation, and classification in medical and biological imaging.

Pharmacometrics

Pharmacometrics is the science of interpreting and understanding pharmacology quantitatively. It involves applying mathematical and statistical models to pharmacological data, supporting decision-making in drug development, regulatory submissions, and clinical practice. Moreover, pharmacometrics is used to optimize drug therapy and dosing regimens for diverse patient populations including children, the elderly or patients with specific conditions such as renal or hepatic impairment or cancer. Pharmacometricians use a variety of modeling techniques to simulate clinical trials, reducing the need for expensive and time-consuming clinical or preclinical trials and aiding in the understanding of complex biological systems. Key pharmacometric methods include population pharmacokinetics (PopPK), pharmacokinetics/pharmacodynamics (PK/PD) modeling, and physiologically-based pharmacokinetic (PBPK) modeling. The insights gained from pharmacometric analyses help in optimizing dosing, enhancing drug efficacy, and minimizing adverse effects facilitating more personalized medicine.

Read more about Pharmacometrics

Digital Science

- Information will follow soon -